Cantabio Pharmaceuticals Inc. conducts novel and innovative research, which is yielding a discovery pipeline and is focused on bringing drug candidates to clinical trials. These approaches are applicable to Parkinson’s, Alzheimer’s and other related neurodegenerative diseases.
